Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ILMN Illumina, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $228.93 +3.0% | $15.40 -3.7% |
| StockIQ Score | 69B- Moderate Risk: High | 35F Weak Risk: High |
| Technical | 85A | 13F |
| Fundamental | 76B+ | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 33F | 38F |
| News | 100A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Illumina (ILMN) outperforms Ascentage Pharma (AAPG) across most categories. Its technical score (83 vs. 18) and fundamental score (76 vs. 35) are significantly stronger, showing better market trends and financial health. While AAPG has slightly higher growth (50 vs. 68) and valuation (38 vs. 33), Illumina’s overall higher scores make it the stronger choice in this comparison.